Benzalkonium chloride (BAC) is a widely used disinfectant/preservative, and respiratory exposure to this compound has been reported to be highly toxic. Spray-form household products have been known to contain BAC together with triethylene glycol (TEG) in their solutions. The purpose of this study was to estimate the toxicity of BAC and TEG mixtures to pulmonary organs using in vitro and in vivo experiments. Human alveolar epithelial (A549) cells incubated with BAC (1-10 μg/mL) for 24 hours showed significant cytotoxicity, while TEG (up to 1000 μg/mL) did not affect cell viability.
| INTRODUCTION
Benzalkonium chloride (BAC) is a widely used cationic surfactant belonging to a group of compounds known as quaternary ammonium compounds (QAC). BAC is a mixture of n-alkylbenzyldimethylammonium chlorides, with various alkyl (R) chain lengths from C 8 H 17 to C 18 H 37 . 1 BACs with an alkyl chain of n = 10-16 are known to have potent bactericidal effects, and are commonly used as disinfectants, antiseptics, and preservatives. 2 Many studies have shown the harmful effects of BAC on the human body, such as skin irritation and allergic contact dermatitis. [3] [4] [5] Highly toxic effects of BAC have also been found in animal studies. BAC orally administered to rats causes significant lethality, and the lethal dose 50 (LD 50 ) has been reported to be 234-525 mg/kg. 6, 7 Pulmonary effects of BAC have particularly been investigated since this preservative has been used in inhalable medications. BAC included in nebulized bronchodilators for treatment of asthma and chronic obstructive pulmonary diseases has been reported to cause bronchoconstriction and bronchospasm. [8] [9] [10] Rodents that singly or repeatedly inhaled BAC show pulmonary irritation, inflammation, and damage to the blood-air barrier. [11] [12] [13] Moreover, BAC administered via oral and intravascular routes in rats causes pulmonary edema and interstitial pneumonia, with a higher tissue concentration of BAC in the lungs than in the blood and other organs. Thus, it has been suggested that lung can be a reservoir of BAC and consequently a target organ for BAC toxicity. 14, 15 Triethylene glycol (TEG) is a liquid used as a solvent, a humectant, and a chemical intermediate. 16 TEG mist or vapor has been used for disinfection because it shows bactericidal activity against pneumococci, streptococci, and staphylococci. [17] [18] [19] TEG is relatively safe for humans, and very low toxicities have been shown in animals administered with TEG via oral, intravenous, and percutaneous routes. 16 The acute oral LD 50 of TEG is reported to be 22 000 mg/kg in rats 20 and more than 18 500 mg/kg in mice. 16 A rodent inhalation test showed that acute respiratory exposure to TEG aerosol is not toxic. 21 However, humans repeatedly exposed to aerosol containing TEG experience coughing, shortness of breath, wheezing, and chest tightness, 16 indicating that chronic inhalation of TEG is potentially harmful to the respiratory organs.
In comparison to the toxicities of individual substances, those of chemical mixtures are quite unpredictable owing to the possibility of toxic interactions between the chemicals, which can induce synergism, addition, potentiation, or antagonism of their effects on biological systems. [22] [23] [24] Some commercial spray-form household products such as sanitizers and deodorants include BAC (0.01%-1.8%, w/v) and TEG (1%-15%, w/v) as disinfectants and/or preservatives in their solutions. 25 Since the air mist particles from these products are inhalable, human respiratory organs can be directly exposed to BAC and TEG.
Nonetheless, the pulmonary effects of BAC and TEG in combination have not been reported. The present study was designed to estimate the combined toxicity of BAC and TEG to lung cells and tissues.
Human alveolar epithelial (A549) cells and rat pulmonary organs were exposed to BAC and TEG either individually or together, and the cellular and clinical responses were observed. The results showed that the BAC and TEG mixture caused more severe pulmonary injury than the individual compounds alone.
| MATERIALS AND METHODS

| Chemicals
All chemicals including BAC and TEG were purchased from SigmaAldrich (St. Louis, MO).
| Cell culture
Human adenocarcinomic alveolar epithelial (A549) cells were obtained from the Korea Cell Bank (Seoul, Korea). Cells were grown in RPMI 1640 medium (Thermo Fisher Scientific Inc., Waltham, MA) containing 10%
heat-inactivated fetal bovine serum (Thermo Fisher Scientific Inc.) and 1% penicillin-streptomycin (Thermo Fisher Scientific Inc.) under standard cell culture conditions (37 C, 5% CO 2 , and 90% humidity).
| Determination of in vitro cytotoxicity
The concentrations of BAC used in in vitro toxicity tests were decided based on blood and/or tissue concentrations of BAC in previous studies.
The concentrations of BAC in the whole blood and lung were 0.06-0.34 μg/g and 0.39-2.75 μg/g, respectively, in rats after oral administration of BAC 250 mg/kg. 14, 15 The serum BAC level of a human individual who accidentally swallowed BAC was 0.16 μg/mL several hours after ingestion. 26 The dose of TEG was determined based on the concen- 1000 μg/mL). To evaluate the combined toxicity, 2 μg/mL of BAC (around its IC 10 of 1.63 μg/mL) and various concentrations of TEG (0, 1, 3, 10, 30, 100, 300, and 1000 μg/mL) were added to the cell culture medium. After 24 hours incubation, cell viability was determined by a
showing the mitochondrial/cytosolic reducing capacity of NAD(P)H oxidoreductase, which converts soluble MTT reagent to insoluble formazan in living cells. 27 Cells were incubated with 200 μg/mL of MTT in culture medium for 2 hours and then the medium was removed. After washing with phosphate-buffered saline (PBS), dimethyl sulfoxide was added to the well. After gentle shaking, the absorbance was measured at 540 nm by microplate reader. The activity of LDH in the culture media released from the cells through the damaged membrane was quantified after 24 hours exposure to the chemicals using a QuantiChrom LDH Kit (BioAssay Systems, Hayward, CA). The activity of LDH from totally disrupted cells treated with PBS containing 1% triton X-100 for 1 hour was considered 100%, and the relative activity of LDH of each group was calculated.
| Colony formation assay
Clonogenic assay was conducted using the method of Franken et al. 28 Cells were incubated in 6-well plates at the density of 250 cells per well overnight. BAC (0.3 μg/mL) with or without TEG (1, 10, 100, or 1000 μg/mL) was incubated with the cells for 10 days. After incubation, the medium was discarded, and the cells were washed with 70%
ethanol followed by staining with 0.5% crystal violet in 20% methanol solution. The numbers and the sizes of colonies were quantified using light microscopy (Olympus Co., Tokyo, Japan). 
| Determination of cellular oxidative stress
| Animals and treatments
Male Sprague-Dawley rats (7 weeks old) were purchased from Ori- 
| BALF analysis
Rats were intraperitoneally injected with 50 mg/kg of tiletamine + zolazepam (Zoletil 50, Virbac; Carros, France) and 15 mg/kg of xylazine hydrochloride (Rumpun, Bayer; Leverkusen, Germany) for anesthetization. BALF was collected via five lavages of the lung with a total of 25 mL PBS (pH 7.4, magnesium-and calcium-free) for analysis of pulmonary toxicity and inflammation. The BALF were centrifuged (200g, 4 C, 10 minutes) and the cell-free supernatant of the first lavage was used for determination of total protein content, LDH activity, TNF-α, and IL-6 levels. Total protein content was determined by a BCA assay kit (iNtRON Biotechnology), and LDH activity was determined using a QuantiChrom LDH Kit (BioAssay Systems). TNF-α and IL-6 levels were quantified using Quantikine enzyme-linked immunosorbent assay kits (R&D Systems; Minneapolis, MN). Centrifuged cell pellets in all lavages were re-suspended in PBS, and total cells were counted using a Vi-Cell XR analyzer (Beckman Coulter; Brea, CA). The cells were fixed on slide glass via centrifugation (1800 rpm, 4 minutes) using a Shadon Cytospin 4 Cytocentrifuge (Thermo Fisher Scientific Inc.) and stained with Diff-Quick (Sysmex Corporation, Kobe, Japan). Macrophages and PMNs were counted using light microscopy (Olympus Co.; Tokyo, Japan).
| Histopathological examination
Lung tissues were fixed in 10% neutral buffered formalin and embedded in paraffin. The tissues were sectioned at 3-5 μm thickness and mounted on slide glass. The slides were stained with hematoxylin and eosin (H&E), and a histopathological examination was performed using dual microscopes (Olympus Co., Tokyo, Japan).
| Statistical analysis
All results were expressed as the mean ± SE. Means of different groups were compared using two-tailed unpaired Student's t tests or one-way analysis of variance (ANOVA, Tukey's multiple comparison test) by
GraphPad Prism version 5.0 software (GraphPad Software Inc., La Jolla, CA).
3 | RESULTS
| Cytotoxicity induced by BAC and TEG in A549 cells
Human alveolar cells treated with BAC (1-10 μg/mL) for 24 hours showed a dramatic decrease in cell viability and increase in cell mem- and BAC (2 μg/mL) significantly decreased cell viabilities ( Figure 2A) and increased LDH leakages ( Figure 2B ) as compared to BAC alone in a TEG-dose-dependent manner. 
| Oxidative stress induced by BAC and TEG in A549 cells
To identify the mechanism of toxicity induced by the two chemicals, cellular oxidative stress was determined, since BAC has been reported to be an ROS-producing agent in human cells. [31] [32] [33] BAC (2 μg/mL) increased ROS production by 8.7% as compared to the control group, while TEG alone (up to 1000 μg/mL) did not affect ROS generation ( Figure 4A ). However, 10 and 100 μg/mL of TEG in combination with BAC (2 μg/mL) elevated ROS production to 22.3% and 28.0%, respectively, as compared to the control ( Figure 4A ). In cells treated with BAC and the highest concentration of TEG (1000 μg/mL), only a 19% increase in ROS production was detected, probably due to the decrease of cell viability in this group. The intracellular concentration of GSH was not changed by TEG alone but was reduced by BAC (2 μg/mL) by about 20% ( Figure 4B ). The addition of 1, 10, and 100 μg/mL TEG to BAC did not make a statistical difference in the 
| Intracellular absorption of BAC in the presence of TEG in A549 cells
Previously, we reported that organic solvent ethylene glycol (EG)increased the cellular distribution of didecyldimethylammonium chloride (DDAC), which also has a structure of QAC, and potentiated the toxicity of DDAC to human bronchial cells. 34 In the present study, we hypothesized that the cellular absorption of BAC could be changed by TEG, and thus the intracellular BAC content was measured using the LC/MS/MS system.
Although the same amount of BAC (2 μg/mL) was treated onto all groups, cells incubated with BAC and TEG together showed a higher intracellular BAC concentration as compared to the cells treated with BAC alone ( Figure 5 ). Thus, it can be suggested that the enhancement of BAC absorption into cells by TEG could be a reason for the increased toxicity.
| Pulmonary toxicity induced by intratracheally instilled BAC and TEG in rats
To evaluate the toxic effects of BAC and TEG mixtures on animal pulmonary organs, rats were directly injected with BAC and TEG individually or together intratracheally. Acutely injected 100 and 200 μg/kg of BAC did not change total protein contents or LDH activities in the BALF, but 400 μg/kg of BAC significantly increased these two biomarkers of pulmonary cell damage ( Figure 6 ) at 1 day posttreatment.
In contrast, TEG (100, 500, and 1000 μg/kg) did not show any pulmonary toxicity ( Figure 6 ). To identify the influence of the BAC and TEG combination, TEG (1000 μg/kg) was mixed with a sub-toxic dose of BAC (100 or 200 μg/kg) and administered to rats. Significantly elevated protein contents ( Figure 7A ) and LDH activities ( Figure 7B) were found at 1 day in the higher dose of BAC (200 μg/kg) mixture group but not in the lower dose of BAC (100 μg/kg) mixture group. At 7 days after exposure, the toxic effects of the chemical mixtures were normalized to the control level, indicating recovery from the pulmonary injury. No differences in body and lung weight were observed between the groups (data not shown).
| Pulmonary inflammation induced by intratracheally instilled BAC and TEG in rats
In the H&E stained lung tissues, no significant differences between control group and single chemical-treated groups were found. The charged nitrogen that remains at the surface of the membrane disturbs the charge distribution, finally resulting in the destruction of cell membrane structure and the leakage of intracellular molecules. [35] [36] [37] Not only microorganisms but also human pulmonary cells can be subjected to the toxicity of QAC including BAC. An in vitro study using human normal bronchial epithelial (BEAS-2B) cells
showed that 2 hours incubation of 0.005 (50 μg/mL) to 0.01 (100 μg/mL) % BAC significantly damages cell membranes and decreases the cell viability. 38 Pulmonary exposure to BAC in rats has also been reported to be highly toxic, with a lethal concentration LDH and total proteins, the biomarkers of pulmonary toxicity, are leaked into bronchoalveolar space from injured bronchial/alveolar cells and damaged airway structures. 42, 43 It has been also shown that inhalation exposures to BAC cause significant increases of BALF protein and LDH in mice 11 and rats. 12, 13 In contrast to BAC, the FIGURE 5 Cellular absorption of BAC in the presence of TEG. A549 cells were exposed to BAC (2 μg/mL) with or without TEG (1-1000 μg/mL) for 24 hours, and the intracellular BAC was quantified by LC/MS/MS. Mean ± SE. Student's t test, **,*** P < 0.01, and 0.001, respectively, vs BAC alone FIGURE 6 Acute pulmonary toxicity induced by BAC or TEG in rats. A, Total protein content in BALF. B, LDH activity in BALF. Male rats were intratracheally instilled with BAC (B; 100, 200, or 400 μg/kg) or TEG (T; 100, 500, or 1000 μg/kg), and the toxicity was determined using BALF at 1 day after exposure. Mean ± SE. Student's t test, * P < 0.05 vs control, # P = 0.06 vs control pulmonary toxicity of TEG is known to be very low; the LC 50 of acute TEG aerosol inhalation by rats is greater than 4400 mg/m 3 . 16 In the present study, TEG did not show any harmful effects on cultured alveolar cells at concentrations up to 1000 μg/mL (0.1%, Figure 1B ) or on rat lung at doses up to 1000 μg/kg (Figures 6 and 7) .
Compared to the single compounds, the BAC and TEG combination led to more potent pulmonary toxicity in our in vitro and in vivo 28 This assay can be used in cancer research to estimate the anti-tumorigenic activities of drug candidates and also in toxicological research to identify the adverse effects of chemicals. 44, 45 In the present study, TEG itself did not affect the colony formation, but remarkably inhibited A549 cell survival and proliferation in combination with BAC ( Figure 3 ).
The results of animal experiments also show that the combination of BAC and TEG can promote unpredictable pulmonary toxicity. BAC and TEG mixture administration also provoked lung inflammatory responses that were not observed in rats treated with each individual compound (Figures 8 and 9 ). Pulmonary inflammation is usually implicated in lung injuries caused by inhaled substances. 46 which can also be sources of these cytokines. [53] [54] [55] [56] Therefore, the BALF concentrations of TNF-α and IL-6 are highly increased in acute pulmonary inflammation. 45, 57 In the present study, elevated BALF TNF-α and IL-6 levels in mixture-administered rats (TEG 1000 μg/kg and BAC 200 μg/kg) were closely associated with the increased PMN recruitment.
Taken together, the BAC and TEG mixture induced inflammatory cell attraction to pulmonary tissues via cytokine secretion, probably by activated macrophages. Since TNF-α also has a cytotoxic effect on cells, 52 acutely induced inflammation might be involved in the toxicity caused by the mixture.
Previously, it was reported that the combination of DDAC, another biocide belonging to the QAC group, and several organic surfactants showed synergistic antimicrobial effects. DDAC at a sublethal concentration exerts bactericidal activity against Staphylococcus aureus in the presence of nonionic surfactants such as polyoxypropylene glycol, polyoxyethylene lauryl ether, and polyoxyethylene isodecyl ether. 58 In that study, it was suggested that nonionic surfactants facilitate the penetration of DDAC into the bacterial membrane.
Recently, we reported the combined toxicity of DDAC and EG to pulmonary cells. DDAC-induced cytotoxicity is potentiated in the presence of nontoxic doses of EG in human bronchial epithelial (BEAS-2B) cells, and the effect is dependent on the concentration of EG. 34 Moreover, rats intratracheally instilled with the mixture of DDAC and EG show significant pulmonary toxicity and inflammation, whereas the individual chemicals do not induce toxicity in respiratory organs. 59 These findings appear to be quite similar to the results of the present study, with the same aspects of cytotoxicity induced by the combination of the QAC and organic solvent. In the previous report, the enhancement of cellular absorption of DDAC facilitated by EG was suggested to be a possible mechanism of toxicity because elevated concentrations of intracellular DDAC were detected in cells treated with both DDAC and EG as compared to cells exposed to DDAC alone. 34 Similarly, in the present study, TEG treatment enhanced the intracellular distribution of BAC in alveolar epithelial cells. The surfactant and/or emulsifying action of the BAC and TEG combination to the cell membrane structure could be a possible reason for the increased penetration of BAC, but the exact mechanism of the altered membrane permeability is unclear.
Along with its effects on cell membrane structure, the influence of BAC on intracellular biomolecules, organelles, and their functions is another possible mechanism of the increased toxicity resulting from higher absorption of BAC into cells by TEG. BAC impairs mitochondrial ATP synthesis and O 2 consumption by direct inhibition of mitochondrial complex I in human corneal epithelial cells. 30 Many studies have shown that oxidative stress induced by BAC is important to its toxicity to human cell lines. Incubation of BAC with cultured human corneal epithelial cells results in dose-dependent increases in ROS production and DNA damage. 33 Significant production of ROS with BAC treatment has also been observed in a human keratinocyte (HaCaT) cell line, and NADPH oxidase is suggested to be the source of the ROS. 32 In human conjunctival epithelial cells, BAC decreases cell membrane integrity, induces chromatin condensation, and promotes excessive formation of reactive oxidants such as H 2 O 2 and superoxide anions. 31 Oxidative stress is usually involved in the inhalable toxicant-associated pathogenesis of human lung diseases. 60, 61 The interactions between oxidative free radicals and cellular macromolecules, such as proteins, DNA, and lipids, lead to impairment of cell functions and finally cell death. 60, 61 GSH is a major cellular antioxidant that protects biomolecules against reactive oxidants by its reducing capacity and is converted to GSSG. 61 In the present study, BAC induced significant oxidative stress in alveolar cells ( Figure 5 ). TEG alone did not alter the ROS production, GSH content, or GSH/GSSG ratio (data not shown), but in combination with BAC aggravated cellular oxidative stress more than BAC alone ( Figure 5 ). Alleviation of mixture-induced cell death by pretreatment with NAC strongly supports that the oxidative stress is an important mechanism of cytotoxicity of the mixture. Peroxidation of membrane lipid by ROS perturbs the bilayer structure and increases membrane permeability. 60, 61 Therefore, the oxidative stress caused by the BAC and TEG mixture in the present results might be also associated with membrane damage in the cells. 
